Scientific and operational resources are available to sponsors conducting trials and studies in Huntington’s disease. An overview of the resource access process is provided below.
We will highlight available platform support and consultation options, discuss your plan and the stage of development of your study/program, and work with you to determine how we can best meet your needs.
In preparation for the introductory meeting, please send us a summary of your areas of interest, topics or questions you would like to discuss, and any relevant non-confidential information.
If required, a CDA can be arranged in advance of initial discussions.
Requirements depend on the type of support that you are requesting. We will work with you to identify your specific needs during the introductory meeting.
To access scientific consultation to support study planning, sponsors are required to submit the following (at minimum).
- Non-confidential data package/protocol synopsis or draft protocol (if available)
- List of questions/topics for discussion
If required, a confidentiality agreement can be arranged.
Scientific consultations will be scheduled following a review of the above information. The format of subsequent consultations can be at a meeting or in writing.